Adjuvant chemoendocrine therapy in postmenopausal breast cancer: Cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference

Aron Goldhirsch, Alan S. Coates, Marco Colleoni, Monica Castiglione-Gertsch, Richard D. Gelber

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Adjuvant chemoendocrine therapy in postmenopausal breast cancer: Cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference'. Together they form a unique fingerprint.

Medicine & Life Sciences